3
ICAP

january, 2018

IMPOWER 22

Project Details

A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection.
https://icap.columbia.edu/where-we-work/icap-ctu/